Last reviewed · How we verify

General anesthesia

Universidade Estadual Paulista Júlio de Mesquita Filho · FDA-approved active Small molecule

General anesthesia depresses the central nervous system to produce unconsciousness, analgesia, and muscle relaxation for surgical procedures.

General anesthesia depresses the central nervous system to produce unconsciousness, analgesia, and muscle relaxation for surgical procedures. Used for Induction and maintenance of general anesthesia for surgical procedures, Sedation in intensive care settings.

At a glance

Generic nameGeneral anesthesia
Also known asMidazolam, Rocuronium, Fentanyl, Propofol, Remifentanil
SponsorUniversidade Estadual Paulista Júlio de Mesquita Filho
Drug classGeneral anesthetic
ModalitySmall molecule
Therapeutic areaAnesthesiology
PhaseFDA-approved

Mechanism of action

General anesthesia works through multiple mechanisms depending on the specific agent used, typically involving enhancement of inhibitory neurotransmission (GABA) and/or suppression of excitatory neurotransmission (glutamate) in the brain. This results in loss of consciousness, suppression of reflexes, and amnesia. The class encompasses intravenous agents (propofol, etomidate, ketamine), inhaled volatile anesthetics (sevoflurane, isoflurane), and nitrous oxide.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: